Who manufactures Kogenate?

Manufacturing – Product safety and quality Bayer places a high priority on product quality throughout the Kogenate FS manufacturing process.

How does Kogenate work?

This product contains a man-made form of factor VIII, also called antihemophilic factor. This product is used to temporarily replace the missing factor VIII, a protein (clotting factor) that is normally in the blood, so that the blood can clot and the bleeding can stop.

What is the difference between Kogenate and Kovaltry?

Stoffman: Clinically, they’re the same. The efficacy and the safety are what we’ve come to expect from Kogenate. Kovaltry is the same molecule so it has the same clinical efficacy and it’s indicated for all the same uses as Kogenate: for prophylaxis, for on-demand therapy and for surgery.

Is Kogenate an 8 factor?

Kogenate® FS Antihemophilic Factor (Recombinant) is a medicine used to replace clotting factor (factor VIII or antihemophilic factor) that is missing in people with hemophilia A.

How is Kogenate made?

Kogenate is produced by providing cells derived from hamsters and grown in the laboratory, with a copy of the human F8 gene. The cells produce the protein and this is then harvested and purified for human use.

Who makes Kovaltry?

Bayer, the Bayer Cross, Kogenate, Kovaltry and Jivi are registered trademarks of Bayer. Access Services by Bayer is a trademark of Bayer.

What type of drug is Kogenate?

Kogenate® FS Antihemophilic Factor (Recombinant) is a medicine used to replace clotting factor (factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Kogenate FS is not used to treat von Willebrand disease.

Is advate self administered?

Administer ADVATE by intravenous (IV) injection after reconstitution. Ask patients to follow the specific preparation and administration procedures provided by their physicians.

What is KOVALTRY used for?

KOVALTRY® is used to treat and control bleeding in adults and children with hemophilia A. KOVALTRY® can reduce the number of bleeding episodes in adults and children with hemophilia A when used regularly (prophylaxis). Your healthcare provider may give you KOVALTRY® when you have surgery.

What is Kogenate used for?

Kogenate® FS Antihemophilic Factor (Recombinant) is a medicine used to replace clotting factor (factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Kogenate FS is used to treat and control bleeding in adults and children with hemophilia A.

What is Kogenate FS used to treat?

Kogenate® FS Antihemophilic Factor (Recombinant) is a medicine used to replace clotting factor (factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Kogenate FS is used to treat and control bleeding in adults and children with hemophilia A. Your healthcare provider may give you Kogenate FS when you have surgery.

What is Kogenate® FS antihemophilic factor?

Learn how your rep can help – with answers, support & more. Kogenate ® FS Antihemophilic Factor (Recombinant) is a medicine used to replace clotting factor (factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Kogenate FS is used to treat and control bleeding in adults and children with hemophilia A.

Does Kogenate FS work for von Willebrand?

Kogenate FS can reduce the number of bleeding episodes in adults and children when used regularly (prophylaxis). Kogenate FS can reduce the risk of joint damage in children without preexisting joint damage when used regularly. Kogenate FS is not used to treat von Willebrand disease.

How many units of Kogenate should I take?

Until healing is complete. The recommended dose for routine prophylaxis is 25 units per kg of body weight three times per week. Kogenate FS is administered by intravenous injection after reconstitution. Patients should follow the specific reconstitution and administration procedures provided by their physicians.